H
Health and Movement Science Year 12 · Module 3 · Health in an Australian and global context
0 XP

Lesson 12 · How does the healthcare system work?

Complementary healthcare: prevention, treatment and supplementing medical care

A large share of Australians use something outside conventional medicine — a supplement, an app, a practitioner — and most do not tell their doctor. That last fact is the one with clinical consequences, and it is the reason this dot point sits inside the healthcare system section rather than beside it.

Syllabus focus. Inquiry question: How does Australia’s healthcare system work towards achieving better health for all Australians? This lesson addresses the dot point: Explain complementary healthcare approaches.
01
Think first, your gut answer
warm-up

Name three things you or someone you know uses for health that a doctor did not prescribe.

For each, write down what it is supposed to do, and how you would find out whether it does. Then note which of the three you would tell a doctor about, and why the others not.

auto-saved
02
What you'll master
intentions
  • Describe the products and services available, and how varied that category is.
  • Explain the use of complementary approaches as a preventative measure.
  • Explain their use in treating a health issue, and where the risk in that lies.
  • Explain their use as a supplement to other medical treatments, which is how they are most often used.
  • Explain complementary healthcare without dismissing it and without endorsing it — the position the evidence actually supports.
03
Key terms
vocabulary
  • Complementary healthcare — health products, practices and services used alongside conventional medical care.
  • Alternative — used instead of conventional care. The distinction is the single most important one in this lesson, because the risk profile is completely different.
  • Integrative care — conventional and complementary approaches used together, coordinated and disclosed, within one plan.
  • Evidence base — the body of research supporting or not supporting a claim; strong for some complementary approaches, weak or absent for others.
  • Placebo effect — genuine improvement arising from expectation, attention and the ritual of care rather than from the specific ingredient.
  • Interaction — one substance changing the effect of another; the main clinical risk from undisclosed supplement use.
  • Listed and registered medicines — Australia regulates lower-risk products for safety and quality without individually assessing every efficacy claim, and higher-risk products with full efficacy assessment.
  • Opportunity cost, clinical version — the harm from what was not done while an ineffective approach was tried.
04
The products and services available
core concept

The category is enormous and internally inconsistent, and the first analytical move is to stop treating it as one thing. Group it by what kind of claim is being made.

  • Ingestible products. Vitamin and mineral supplements, herbal preparations, protein and sports supplements, probiotics. Sold in supermarkets and pharmacies as well as specialist shops.
  • Practitioner-delivered services. Naturopathy, remedial massage, acupuncture, chiropractic, osteopathy, aromatherapy. Some of these professions are formally registered and others are not, which changes what recourse a consumer has.
  • Mind–body practices. Yoga, meditation, mindfulness, tai chi. These sit closest to conventional care, because several have reasonable evidence for specific outcomes such as stress and chronic pain.
  • Health apps and websites. The fastest-growing part of the category: symptom checkers, diet and fitness trackers, sleep and mental wellbeing apps, and online information and advice.
  • Devices and gadgets sold with health claims, from wearables through to items with no plausible mechanism at all.

The evidence within this list ranges from good to absent. Treating “complementary medicine” as a single thing to be defended or attacked is the mistake both its advocates and its critics make, and an answer that sorts it by evidence rather than by category is a better answer.

Two facts about the Australian setting worth knowing. Products are regulated for safety and quality and, for lower-risk products, the specific efficacy claim is generally not individually assessed — so “approved” means “unlikely to hurt you and contains what it says”, not “proven to work”. And practitioner regulation is uneven: some occupations are nationally registered with enforceable standards, others are self-regulated, so the protection a consumer has depends on which practitioner they walk in to see.

In your book. Write the five groups, and beside each write “good”, “mixed” or “little” for the strength of evidence you would expect. Then note which of your three items from card 01 sit in which group.

Quick check: A lower-risk complementary product is approved for sale in Australia. This most reliably tells a consumer that:

05
As a preventative measure
core concept

This is where complementary approaches are used most and where the case for them is strongest, because prevention is mostly about sustained behaviour and complementary practice is often good at sustaining behaviour.

  • What people are trying to do. Maintain wellbeing rather than treat a diagnosis; manage stress; support sleep, digestion, immunity or energy; and stay in control of their own health.
  • Where the evidence supports it. Mind–body practices have reasonable evidence for stress, anxiety and chronic pain; yoga and tai chi improve balance and strength, which matters directly for falls prevention in older people; and apps that support activity, sleep or quitting smoking can genuinely change behaviour when they are well designed.
  • Where it is weak. Routine supplementation in a person eating adequately mostly produces expensive urine. Supplements correct deficiencies; they do not add benefit above sufficiency, and a few are harmful in excess.
  • The mechanism that is often the real one. A practitioner who gives a long consultation, asks about sleep, stress, diet and life circumstances, and follows up, is delivering attention, continuity and behavioural support — which are effective, and are exactly what a short subsidised consultation struggles to provide. A great deal of complementary healthcare's value is delivered this way, and saying so is a stronger analysis than either dismissal or endorsement.

Two risks specific to prevention use: money spent on ineffective products is money not spent on things that work, which matters most for people with least; and confidence in a preventative product can displace an effective measure — a supplement believed to “support immunity” standing in for vaccination is the clearest example.

In your book. Write the sentence about attention, continuity and behavioural support in your own words. It explains most of what this dot point asks you to explain, and it is the observation markers reward.

True or false: Part of the benefit people get from complementary practitioners comes from long consultations, attention and follow-up, which are effective in themselves and are hard to provide in a short subsidised appointment.

06
Treating the health issue — and where the real risk is
core concept

Using a complementary approach to treat a condition is the use with the strongest evidence for some things and the greatest potential for harm in others. The determining factor is not the therapy; it is whether it is used instead of, or alongside, effective treatment.

  • Where it works. Several approaches have reasonable evidence for specific symptoms: some manual therapies for some kinds of back pain, mindfulness-based approaches for chronic pain and for relapse prevention in depression, and some herbal preparations for defined conditions. The claims that hold up are narrow and specific, which is a useful signal in itself.
  • Where it does not. Broad claims — to detoxify, boost immunity, balance energy or cure serious disease — are unsupported, and the breadth of the claim is a reliable warning sign. A treatment that works for everything works for nothing in particular.
  • The serious harm is rarely the therapy itself. It is the delay. Choosing an ineffective alternative for a serious, treatable condition costs the window in which treatment works. Cancer is the case where this has been studied most, and delayed conventional treatment is associated with substantially worse survival. That is the clinical version of opportunity cost, and it is the strongest single argument in this lesson.
  • Direct harms exist too. Some herbal preparations are toxic in some doses; some products are contaminated or contain undeclared ingredients; and manipulation carries a small risk in some circumstances.

Complementary is not the same word as alternative. Used alongside effective care, most of these approaches are low risk. Used instead of it, for a serious condition, the risk is the disease.

Fill the gaps. An approach used alongside conventional care is ; one used instead of it is . Genuine improvement arising from expectation and the ritual of care rather than from the specific ingredient is the effect.

07
As a supplement to other medical treatments
core concept

This is how complementary approaches are most often actually used, and it is where the healthcare system has the clearest job to do.

  • What it looks like. Someone having cancer treatment also using meditation for anxiety and acupuncture for nausea. Someone with chronic back pain using medication, physiotherapy and yoga together. Someone with a chronic illness taking prescribed medicines and also a herbal preparation a relative recommended.
  • Why it can help. Conventional treatment often targets the disease while leaving the experience of illness — anxiety, nausea, pain, sleep, loss of control — less well addressed. Complementary approaches are frequently better at that, and feeling in control of part of your own treatment is itself associated with better engagement.
  • Why disclosure is the whole issue. A substantial share of people using complementary products do not tell their doctor, often because they expect to be dismissed. Undisclosed use creates real risk: some herbal preparations interact with anticoagulants, some affect how the liver metabolises other drugs, some raise bleeding risk around surgery, and high-dose antioxidants may interfere with some cancer treatments. The danger is not the product; it is the secret.
  • What good practice looks like. Clinicians who ask routinely and without judgement get told, and can then advise. That is integrative care: everything on one plan, known to everyone treating the person — which is the person-centred principle from Lesson 9 applied to this dot point.

Note the circularity, because it is the analysis: dismissal produces non-disclosure, and non-disclosure produces the risk that dismissal was worried about. Breaking that loop is a system behaviour, not a patient behaviour.

In your book. Write “the danger is not the product, it is the secret” and underneath it write the loop: dismissal → non-disclosure → interaction risk → more dismissal. Then write who has to break it, and why it cannot be the patient.

Two truths and a lie. One of these statements is false. Find it.

08
Explaining this without dismissing or endorsing
core concept

The command word in this dot point is “explain”, and the strongest explanations do four things.

  • Separate the category. Judge specific approaches for specific uses, not “complementary medicine” as a whole. Evidence exists for parts of it and not for others.
  • Take the reasons for use seriously. People use these approaches because conventional care can be rushed, because it treats disease better than illness, because they want agency, because it fits their culture and beliefs, and sometimes because conventional care has not helped. Those are reasons, and describing them is analysis; calling users misinformed is not.
  • Be precise about the risk. The main risks are delay of effective treatment, interaction through non-disclosure, and cost. Note that these are risks of how an approach is used more than of what it is.
  • Point at the system implication. Widespread use tells you something about the healthcare system: that people want time, attention and a whole-person account of their health, and are prepared to pay out of pocket for it. That is a finding about primary care as much as about naturopathy.

The defensible position, and the one an examiner is looking for: complementary approaches are widely used, variable in evidence, generally low risk alongside conventional care and potentially seriously harmful in place of it — and their use should be disclosed and discussed rather than driven underground.

The two questions that decide the risk of a complementary approach A two-by-two grid. The horizontal axis asks whether the approach is used alongside conventional care or instead of it. The vertical axis asks whether the use is disclosed to the treating clinician or not. The four cells are labelled: alongside and disclosed, integrative care, lowest risk; alongside and undisclosed, interaction risk, the most common real situation; instead of and disclosed, risk of delay but the clinician can advise; and instead of and undisclosed for a serious condition, the highest risk cell. Beneath the grid a loop diagram shows dismissal leading to non-disclosure leading to interaction risk leading back to dismissal, with a note that the clinician has to break the loop because the patient cannot. The therapy is rarely the risk. These two questions are. used ALONGSIDE conventional care used INSTEAD OF conventional care disclosed not disclosed Integrative care — lowest risk Everything on one plan, known to everyone treating the person. Interactions can be checked, and the benefit for symptoms and wellbeing is kept. Delay, but visible The clinician knows and can explain what is being given up. For a minor self-limiting problem this may be reasonable; for a serious condition it is not. Interaction risk — the common case A large share of users do not tell their clinician. Anticoagulants, liver metabolism, bleeding risk around surgery. The danger is the secret. Highest risk An effective treatment is not given, and nobody knows to intervene. The harm is the disease, and the cost is the window in which treatment works. The loop that keeps people in the bottom-left cell clinician dismisses or is expected to patient does not tell use goes unrecorded interaction risk unmanaged, unseen the clinician breaks the loop
Two questions, four outcomes. Note that the two cells on the left differ only in whether anyone was told — which is why “ask routinely and without judgement” is a clinical intervention rather than a courtesy.
09
Activity 1 · Place four uses on the grid
activity

For each, say which cell of the grid it belongs in, what the main risk is, and what you would advise.

1

A person having chemotherapy uses meditation for anxiety and has told the oncology team.

2

A person on a blood-thinning medicine takes a herbal preparation daily and has not mentioned it.

3

A person declines recommended treatment for an early, curable cancer in favour of a dietary protocol, and has told their doctor.

4

A person with mild seasonal symptoms uses a herbal tea instead of an over-the-counter medicine.

Match each use of complementary healthcare to what it is doing.

  • Preventative
  • Treating the issue
  • Supplementing treatment
  • Alternative
  • Tai chi to maintain balance and strength, so falls are less likely
  • A manual therapy used for an episode of back pain
  • Acupuncture for nausea during chemotherapy, disclosed to the team
  • A dietary protocol used in place of recommended cancer treatment
10
Activity 2 · Design the question a clinician should ask
activity

Write the exact wording of a question a general practitioner could ask every patient about complementary use, designed so that a person who expects to be judged still answers honestly.

Then explain, in a short paragraph, why the wording matters clinically — what specific harm your question is preventing — and say what the practitioner should do with a “yes” that turns out to involve a product with no evidence and no interaction risk.

auto-saved

Lock it in. In one sentence, explain why the distinction between complementary and alternative use matters more than any judgement about the therapy itself.

Explain5 marks

Explain the role complementary healthcare approaches play alongside conventional medical treatment.

1
Unpack the verb

Explain asks why people use these approaches and how they function alongside conventional care. Listing therapies is description; the marks are for the role they play and why.

Plan: name the principle, build linked pairs covering each role, then answer the question directly.

The word “complementary” carries the whole answer. It means alongside, not instead of — and the distinction is examinable.
Assess6 marks

Assess the value of complementary healthcare products and services for the Australian health consumer.

1
Unpack the verb

Assess requires a judgement of value against criteria. The stem asks about value to the consumer, so cost and evidence quality belong in your criteria.

Plan: criteria, the case for, the case against, a verdict that commits, then a qualification.

Assess and Evaluate carry the same obligation. Neither is satisfied by a balanced summary with no conclusion.
11
Revisit your thinking
reflection

Go back to card 01. You named something you would not tell a doctor about, and gave a reason. Was the reason that you expected to be dismissed? If so, you have just described the loop in the diagram from the inside — and you now know what the clinician would need to do differently.

auto-saved
01
Multiple choice
1 mark each

MC 1. The key difference between complementary and alternative use of a therapy is that:

  • A. complementary therapies are regulated and alternative therapies are not
  • B. complementary means used alongside conventional care; alternative means used instead of it
  • C. complementary therapies have no evidence base at all
  • D. alternative therapies are delivered only by registered practitioners

MC 2. The most serious harm associated with using an unproven approach instead of effective treatment for a serious condition is usually:

  • A. direct toxicity of the product
  • B. the cost of the product
  • C. delay, which costs the window in which treatment works
  • D. the placebo effect

MC 3. Undisclosed use of a herbal preparation is a clinical risk mainly because:

  • A. herbal preparations are always toxic
  • B. it can interact with prescribed medicines without anyone being able to check for it
  • C. it prevents the patient from attending appointments
  • D. it invalidates the patient's private health cover

MC 4. Which is the most reliable warning sign about a health product?

  • A. It is sold in a pharmacy
  • B. It makes a very broad claim, such as to detoxify or to boost immunity
  • C. It has a long history of traditional use
  • D. It is more expensive than a comparable product

MC 5. Widespread use of complementary healthcare is best read as evidence that:

  • A. conventional medicine does not work
  • B. people want time, attention and a whole-person account of their health, and will pay out of pocket for it
  • C. complementary therapies are more effective than conventional treatment
  • D. health regulation in Australia has failed
02
Short answer questions
extended response

SA 1. Understand Band 4 Describe the range of complementary healthcare products and services available in Australia, and explain one way they are used as a preventative measure. (4 marks)

auto-saved

SA 2. Analyse Band 5 Explain why disclosure of complementary healthcare use to a treating clinician matters, and why non-disclosure is common. (5 marks)

auto-saved

SA 3. Evaluate Band 6 Explain complementary healthcare approaches, and evaluate their place in the Australian healthcare system. (6 marks)

auto-saved
📖 Comprehensive answers (click to reveal)

Multiple choice: 1 → B. 2 → C. 3 → B. 4 → B. 5 → B.

Activity 1 model answers: 1 → Alongside and disclosed — integrative care, lowest risk. Advice: continue; meditation has reasonable evidence for anxiety and there is no interaction with treatment. 2 → Alongside and undisclosed — interaction risk, and the most common real situation. Advice: ask routinely and without judgement, check the specific interaction, and adjust or stop the preparation rather than the medicine. 3 → Instead of, and disclosed — delay, but visible. Advice: the clinician can and should explain exactly what is being given up in terms of survival, keep the relationship open so the door back is not closed, and re-offer treatment; disclosure is the one thing making intervention possible here. 4 → Instead of, and low stakes — a minor self-limiting problem where the opportunity cost is small. Advice: reasonable; note that the same reasoning would not transfer to a serious condition.

SA 1 (4 marks): Range described across more than one kind of product or service — ingestible products, practitioner-delivered services, mind–body practices, and health apps and websites [2]. One preventative use explained with a mechanism [1] — for example, tai chi or yoga maintaining balance and strength and so reducing falls risk, or a well-designed app supporting sustained behaviour change. A qualifying observation for the fourth mark [1] — for example, that evidence varies greatly across the category, or that routine supplementation adds little above sufficiency.

SA 2 (5 marks): Why it matters: some preparations interact with prescribed medicines, affect metabolism or bleeding risk, and cannot be managed if unknown [2]. Why non-disclosure is common: patients expect dismissal or judgement, they do not regard a supplement as a medicine, or they are not asked [2]. The analytical point for the fifth mark: dismissal produces non-disclosure and non-disclosure produces the risk, so the loop must be broken by the clinician asking routinely and without judgement — it cannot be broken by the patient [1].

SA 3 (6 marks): Explanation covering all three syllabus uses — preventative, treating the issue, and supplementing other treatment — with an example of each [2]. The products and services described with recognition that evidence within the category ranges from reasonable to absent, and that regulation assures safety and quality more than efficacy [1]. Benefits evaluated: symptom and wellbeing gains conventional treatment addresses less well, agency, cultural fit, and the value of time and attention [1]. Risks evaluated: delay of effective treatment, interaction through non-disclosure, and cost, with the observation that these are risks of how an approach is used rather than of what it is [1]. Judgement: widely used, variable in evidence, generally low risk alongside conventional care and potentially seriously harmful in place of it, so the system's task is to bring use into the open rather than to endorse or dismiss it — and the scale of use is itself evidence about what people find missing in conventional primary care [1].

01
Consolidate what you have just learned
review

The grid is the transferable tool: two questions — alongside or instead, disclosed or not — settle the risk of almost any case you will be given. Everything else is detail about a specific therapy.

The next lesson is the natural continuation. If the evidence within this category ranges from good to absent, and the labelling does not reliably tell you which is which, how is anyone supposed to decide? That is what being a critical health consumer means.

Mark lesson as complete

Tick when you've finished the practice and review.